advisorsecurities master

ALMSAlumis Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
11596
Ticker
ALMS
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2024-06-28
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
ALMS

Detail

Enriched 2026-08-14 20:47

Market cap
$3,257,420,089
Shares outstanding (class)
123,432,072
Shares outstanding (weighted)
127,491,980
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
227
Location
SOUTH SAN FRANCISCO, CA
Description

Alumis Inc is a clinical-stage biopharmaceutical company with an initial focus on developing its two Tyrosine Kinase 2 ("TYK2") inhibitors: envudeucitinib ("envu"), an allosteric TYK2 inhibitor for the treatment of PsO and SLE; and A-005, a central nervous system ("CNS") penetrant allosteric TYK2 inhibitor, to offer the therapeutic benefit of TYK2 inhibition within the CNS for a broad range of neuroinflammatory and neurodegenerative diseases.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data